BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2022 4:55:04 AM | Browse: 222 | Download: 390
Publication Name World Journal of Clinical Cases
Manuscript ID 79054
Country China
Received
2022-07-30 15:09
Peer-Review Started
2022-07-30 15:10
To Make the First Decision
Return for Revision
2022-09-03 10:32
Revised
2022-09-07 15:58
Second Decision
2022-09-26 03:20
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-09-27 01:11
Articles in Press
2022-09-27 01:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-10-12 02:12
Publish the Manuscript Online
2022-10-27 04:55
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Intestinal microbiota in the treatment of metabolically associated fatty liver disease
Manuscript Source Unsolicited Manuscript
All Author List Ji-Shuai Wang and Jin-Chun Liu
ORCID
Author(s) ORCID Number
Jin-Chun Liu http://orcid.org/0000-0002-1984-6802
Funding Agency and Grant Number
Funding Agency Grant Number
Scientific and Technological Achievements Transformation Guidance Special of Shanxi Province in China 201904D131030
Corresponding Author Jin-Chun Liu, MD, Chief Doctor, Full Professor, Department of Gastroenterology, The First Hospital of Shanxi Medical University, No. 85 Jiefangnan Road, Taiyuan 030001, Shanxi Province, China. zxr610624@163.com
Key Words Intestinal microbiota; Metabolically associated fatty liver disease; Gut-liver axis; Adipokines; Therapy
Core Tip Recent animal studies and Clinical researches have placed the gut microbiota as a potentially important player in the pathogenesis of metabolically associated fatty liver disease (MAFLD).It is logical to target  the gut microbiota to develop new strategies for MAFLD therapy.In addition, we assessed the therapeutic potential of intestinal microbiota manipulation for treating MAFLD and discussed the specific doses and duration of use can provide more help for clinicians in choosing treatment options.
Publish Date 2022-10-27 04:55
Citation Wang JS, Liu JC. Intestinal microbiota in the treatment of metabolically associated fatty liver disease. World J Clin Cases 2022; 10(31):11240-11251
URL https://www.wjgnet.com/2307-8960/full/v10/i31/11240.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i31.11240
Full Article (PDF) WJCC-10-11240.pdf
Full Article (Word) WJCC-10-11240.docx
Manuscript File 79054_Auto_Edited-JLW.docx
Answering Reviewers 79054-Answering reviewers.pdf
Audio Core Tip 79054-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 79054-Conflict-of-interest statement.pdf
Copyright License Agreement 79054-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 79054-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 79054-Language certificate.pdf
Peer-review Report 79054-Peer-review(s).pdf
Scientific Misconduct Check 79054-Bing-Wang LL-2.png
Scientific Editor Work List 79054-Scientific editor work list.pdf